Follow The Filings

MGTX Meiragtx Holdings PLC

Health Care, filed as MEIRAGTX HLDGS PLC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 4.3%
  • $48M
  • 1 add

In 2026 Q2 James Silverman added to Meiragtx.

Who owns this now

Largest portfolio weights among holders, up to 4.3% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman Add 4.3%

Who owns MGTX

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management 4.3%, was 2.4% Add +67.2% 3,550,000 $48M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MGTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MGTX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $4.7M sold by 3 insiders under 10b5-1 plans
  1. Richard Giroux CFO
    Planned sale
    $557K 56,000 shares at $9.95 6.2% of stake
    Traded Oct 20 Filed Oct 20
  2. Stuart Naylor Chief Sci Ofcr, Ophthalmology
    Planned sale
    $294K 27,659 shares at $10.64 4.3% of stake
    Traded Oct 6 Filed Oct 6
  3. Alexandria Forbes CEO
    Planned sale
    $859K 62,000 shares at $13.86 4.5% of stake
    Traded Aug 18 Filed Aug 18
  4. Richard Giroux CFO
    Planned sale
    $701K 56,000 shares at $12.51 5.8% of stake
    Traded Jul 21 Filed Jul 21
  5. Stuart Naylor Chief Sci Ofcr, Ophthalmology
    Planned sale
    $409K 27,659 shares at $14.80 4.1% of stake
    Traded Jul 7 Filed Jul 7
  6. Alexandria Forbes CEO
    Planned sale
    $569K 62,000 shares at $9.17 4.3% of stake
    Traded May 19 Filed May 19
  7. Richard Giroux CFO
    Planned sale
    $572K 56,000 shares at $10.22 5.4% of stake
    Traded Apr 21 Filed Apr 21
  8. Stuart Naylor Chief Dev. Officer
    Planned sale
    $259K 27,661 shares at $9.36 4% of stake
    Traded Apr 7 Filed Apr 7
  9. Alexandria Forbes CEO
    Planned sale
    $459K 62,000 shares at $7.41 4.1% of stake
    Traded Mar 24 Filed Mar 24
  10. Richard Giroux CFO
    Planned sale
    $213K 24,000 shares at $8.87 2.8% of stake
    Traded Oct 21, 2025 Filed Oct 21, 2025
  11. Alexandria Forbes CEO
    Planned sale
    $399K 47,500 shares at $8.39 3.5% of stake
    Traded Oct 7, 2025 Filed Oct 7, 2025

Also filed in the last 12 months, not counted as buying or selling: 16 option exercises, 15 share withholdings for taxes, 3 gifts, 1 stock grant, and 1 sale back to the company.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 1.01,1.02,2.03,3.02,7.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
DEF 14A
DEFA14A
SCHEDULE 13D/A —
8-K 1.01,9.01
8-K 1.01,9.01
424B5

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$84.03M -$147.79M -$114.2M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $159.62M $123.52M $91.76M
Total non-current assets * $167.12M $146.23M $152.67M
Total assets $326.74M $269.75M $244.43M
Total current liabilities $67.08M $60.78M $122.56M
Total non-current liabilities * $121.49M $141.14M $127.67M
Total equity $138.18M $67.83M -$5.79M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$105.36M -$104.5M -$46.36M
Cash from investing $34.03M $23.48M -$4.11M
Cash from financing $84.02M $54.53M $12.27M
Net change in cash * $12.69M -$26.48M -$38.19M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.